AI assistant
Sending…
Jazz Pharmaceuticals plc — Director's Dealing 2015
Apr 23, 2015
30751_dirs_2015-04-23_72150156-dd47-471c-bfd3-19e75904ca01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-04-13
Reporting Person: Smith Karen L. (Global Head of R&D and CMO)
More from Jazz Pharmaceuticals plc
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2